BRIEF—Convert Pharmaceuticals appoints new CEO

Belgian biotech Convert Pharmaceuticals has appointed Mariola Söhngen as chief executive.

The Liège-based firm is gearing up for clinical testing of its lead oncology candidate.

In 2000 Dr Söhngen co-founded PAION, a German biopharmaceutical company, serving as CMO and managing director until 2015, when she became CEO of Mologen, a German immuno-oncology company.